Yoshida K - Search Results

1

Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.

Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, Chida M, Sato M, Toyooka S, Yoshida K, Okada Y, Sato Y, Okada M, Okumura M, Chihara K, Fukuchi E, Miyata H. Endo S, et al. Among authors: yoshida k. Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1182-1189. doi: 10.1093/ejcts/ezx190. Eur J Cardiothorac Surg. 2017. PMID: 28977408 Free PMC article.

2

Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.

Kato Y, Peled N, Wynes MW, Yoshida K, Pardo M, Mascaux C, Ohira T, Tsuboi M, Matsubayashi J, Nagao T, Ikeda N, Hirsch FR. Kato Y, et al. Among authors: yoshida k. J Thorac Oncol. 2010 Oct;5(10):1551-8. doi: 10.1097/JTO.0b013e3181e9da60. J Thorac Oncol. 2010. PMID: 20697298 Free PMC article.

3

Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.

Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N. Saji H, et al. Among authors: yoshida k. J Thorac Oncol. 2011 Nov;6(11):1865-71. doi: 10.1097/JTO.0b013e31822a35c3. J Thorac Oncol. 2011. PMID: 21964529 Free article.

4

Early experience using the da Vinci Surgical System for the treatment of mediastinal tumors.

Kajiwara N, Taira M, Yoshida K, Hagiwara M, Kakihana M, Usuda J, Uchida O, Ohira T, Kawate N, Ikeda N. Kajiwara N, et al. Among authors: yoshida k. Gen Thorac Cardiovasc Surg. 2011 Oct;59(10):693-8. doi: 10.1007/s11748-010-0790-9. Epub 2011 Oct 8. Gen Thorac Cardiovasc Surg. 2011. PMID: 21984137

5

EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology.

Mascaux C, Wynes MW, Kato Y, Tran C, Asuncion BR, Zhao JM, Gustavson M, Ranger-Moore J, Gaire F, Matsubayashi J, Nagao T, Yoshida K, Ohira T, Ikeda N, Hirsch FR. Mascaux C, et al. Among authors: yoshida k. Clin Cancer Res. 2011 Dec 15;17(24):7796-807. doi: 10.1158/1078-0432.CCR-11-0209. Epub 2011 Oct 12. Clin Cancer Res. 2011. PMID: 21994417 Free PMC article.

6

Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.

Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N. Shimada Y, et al. Among authors: yoshida k. J Thorac Oncol. 2012 Aug;7(8):1263-70. doi: 10.1097/JTO.0b013e31825cca6e. J Thorac Oncol. 2012. PMID: 22673056 Free article.

7

Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer.

Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M, Usuda J, Kajiwara N, Ohira T, Ikeda N. Shimada Y, et al. Among authors: yoshida k. Chest. 2013 Jun;143(6):1626-1634. doi: 10.1378/chest.12-1717. Chest. 2013. PMID: 23348916

8

Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence.

Saji H, Tsuboi M, Shimada Y, Kato Y, Hamanaka W, Kudo Y, Yoshida K, Matsubayashi J, Usuda J, Ohira T, Ikeda N. Saji H, et al. Among authors: yoshida k. Oncol Rep. 2013 May;29(5):1902-6. doi: 10.3892/or.2013.2332. Epub 2013 Mar 6. Oncol Rep. 2013. PMID: 23468017

9

A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.

Saji H, Tsuboi M, Shimada Y, Kato Y, Yoshida K, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N. Saji H, et al. Among authors: yoshida k. Chest. 2013 Jun;143(6):1618-1625. doi: 10.1378/chest.12-0750. Chest. 2013. PMID: 23740149

10

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification.

Shimada Y, Saji H, Nomura M, Matsubayashi J, Yoshida K, Kakihana M, Kajiwara N, Ohira T, Ikeda N. Shimada Y, et al. Among authors: yoshida k. Onco Targets Ther. 2013 Nov 8;6:1597-604. doi: 10.2147/OTT.S52353. eCollection 2013. Onco Targets Ther. 2013. PMID: 24235845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,842 results

Search Page

Filters